Skip to main content

RHUMBLINE ADVISERS

Position in NKTR — Nektar Therapeutics

CIK 1115418 BOSTON, MA

Position in NKTR

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$3,008,392
+$2,965,222 QoQ
Shares Held
43,094
+7082.3% QoQ
Ownership
0.126%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#79
of 239 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 21% Shared 0% None 79%

Common Shares in NKTR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. NKTR ranks #73 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NKTR

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,008,392 43,094
2026-03-31 $43,170 600
2025-12-31 $4,228 100
2025-09-30 $5,690 100
2025-03-31 $150,797 221,761
2024-12-31 $167,226 179,813
2024-09-30 $238,082 183,140
2024-06-30 $229,543 185,116
2024-03-31 $4,951 5,324
2023-12-31 $2,981 5,324
2023-09-30 $3,194 5,324
2023-06-30 $8,144 14,043
2023-03-31 $432,338 617,626
2022-12-31 $1,303,766 576,888
2022-09-30 $1,823,484 569,839
2022-06-30 $2,102,346 553,249
2022-03-31 $2,381,145 441,771
2021-12-31 $5,845,520 432,681
2021-09-30 $8,584,790 477,995
2021-06-30 $8,461,184 493,076
2021-03-31 $9,968,500 498,425
2020-12-31 $8,457,789 497,517
2020-09-30 $7,934,748 478,285
2020-06-30 $11,336,194 489,473
2020-03-31 $8,407,974 471,035